Publication Cover
Materials Technology
Advanced Performance Materials
Volume 31, 2016 - Issue 6
272
Views
19
CrossRef citations to date
0
Altmetric
Research Paper

An investigation on the effect of β-CD modified Fe3O4 magnetic nanoparticles on aggregation of amyloid b peptide (25-35)

, , , &
Pages 315-321 | Received 22 Dec 2014, Accepted 27 Feb 2015, Published online: 06 Feb 2016

References

  • F. Chiti and C. M. Dobson: ‘Protein misfolding, functional amyloid, and human disease’, Annu. Rev. Biochem., 2006, 75, 333–366.
  • Selk D. J.: ‘Folding proteins in fatal ways’, Nature, 2003, 426, 900–904.
  • Woodard D., Bell D., Tipton D., Durrance S., Cole L., Li B., Li B. and Xu S.: ‘Gel formation in protein amyloid aggregation: a physical mechanism for cytotoxicity’, PLoS One, 2014, 9, e94789.
  • Colletier J. P., Laganowsky A., Landau M., Zhao M., Soriaga A. B., Goldschmidt L., Flot D., Cascio D., Sawaya M. R. and Eisenberg D.: ‘Molecular basis for amyloid-β polymorphism’, Proc. Natl. Acad. Sci. U.S.A., 2011, 108, 16938–16943.
  • Portelius E., Zetterberg H., Gobom J., Andreasson U. and Blennow K.: ‘Targeted proteomics in Alzheimer's disease: focus on amyloid-β’, Expert Rev. Proteomics, 2008, 5, 225–237.
  • Skaat H., Corem-Slakmon E., Grinberg I., Last D., Goez D., Mardor Y. and Margel S.: ‘Antibody-conjugated, dual-modal, near-infrared fluorescent iron oxide nanoparticles for antiamyloidgenic activity and specific detection of amyloid-β fibrils’, Int. J. Nanomedicine, 2013, 8, 4063–4076.
  • Tsai Y. C., Lee Y. M., Lam K. K., Lin J. F., Wang J. J., Yen M. H. and Cheng P. Y.: ‘The role of heat shock protein 70 in the protective effect of YC-1 on β-amyloid-induced toxicity in differentiated PC12 cells’, PLoS One, 2013, 8, e69320.
  • Hughes E., Burke R. M. and Doig A. J.: ‘Inhibition of toxicity in the β-amyloid peptide fragment β-(25–35) using N-methylated derivatives a generalstrategytoprevent amyloidformation’, J. Biol. Chem., 2000, 275, 25109–25115.
  • Ittner L. M. and Götz J.: ‘Amyloid-β and tau a toxic pas de deux in Alzheimer's disease’, Nat. Rev. Neurosci., 2011, 12, 67–72.
  • Necula M., Kayed R., Milton S. and Glabe C. G.: ‘Small molecule inhibitors of aggregation indicate that amyloid β oligomerization and fibrillization pathways are independent and distinct’, J. Biol. Chem., 2007, 282, 10311–10324.
  • Ladiwala A. R. A., Dordick J. S. and Tessier P. M.: ‘Aromatic small molecules remodel toxic soluble oligomers of amyloid β through three independent pathways’, J. Biol. Chem., 2011, 286, 3209–3218.
  • Spuch C., Saida O. and Navarro C.: ‘Advances in the treatment of neurodegenerative disorders employing nanoparticles’, Recent Pat. Drug Deliv. Formul., 2012, 6, 2–18.
  • Issa B., Obaidat I. M., Albiss B. A. and Haik Y.: ‘Magnetic nanoparticles: surface effects and properties related to biomedicine applications’, Int. J. Mol. Sci., 2013, 14, 21266–21305.
  • Saptarshi S. R., Duschl A. and Lopata A. L.: ‘Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle’, J. Nanobiotechnology, 2013, 11, 26.
  • Pai A. S., Rubinstein I. and Önyüksel H.: ‘PEGylated phospholipid nanomicelles interact with β-amyloid (1–42) and mitigate its β-sheet formation, aggregation and neurotoxicity in vitro’, Peptides, 2006, 27, 2858–2866.
  • Saraiva A. M., Cardoso I., Saraiva M. J., Tauer K., Pereira M. C., Coelho M. A., Möhwald H. and Brezesinski G.: ‘Randomization of amyloidβ-peptide (1-42) conformation by sulfonated and sulfated nanoparticles reduces aggregation and cytotoxicity’, Macromol. Biosci., 2010, 10, 1152–1163.
  • Kim J. E. and Lee M.: ‘Fullerene inhibits β-amyloid peptide aggregation’, Biochem. Biophys. Res. Commun., 2003, 303, 576–579.
  • Rocha S., Thünemann A. F., Pereira M. D. C., Coelho M., Möhwald H. and Brezesinski G.: ‘Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide’, Biophys. Chem., 2008, 137, 35–42.
  • Cabaleiro-Lago C., Quinlan-Pluck F., Lynch I., Lindman S., Minogue A. M., Thulin E., Walsh D. M., Dawson K. A. and Linse S.: ‘Inhibition of amyloid β protein fibrillation by polymeric nanoparticles’, J. Am. Chem. Soc., 2008, 130, 15437–15443.
  • Cabaleiro-Lago C., Quinlan-Pluck F., Lynch I., Dawson K. A. and Linse S.: ‘Dual effect of amino modified polystyrene nanoparticles on amyloid β protein fibrillation’, ACS. Chem. Neurosci., 2010, 1, 279–287.
  • Yoo S. I., Yang M., Brender J. R., Subramanian V., Sun K., Joo N. E., Jeong S. H., Ramamoorthy A. and Kotov N. A.: ‘Inhibition of amyloid peptide fibrillation by inorganic nanoparticles: functional similarities with proteins’, Angew. Chem. Int. Ed., 2011, 50, 5110–5115.
  • Bellova A., Bystrenova E., Koneracka M., Kopcansky P., Valle F., Tomasovicova N., Timko M., Bagelova J., Biscarini F. and Gazova Z.: ‘Effect of Fe3O4 magnetic nanoparticles on lysozyme amyloid aggregation’, Nanotechnology, 2010, 21, 065103.
  • Wahlström A., Cukalevski R., J. Danielsson Jr, Jarvet H., Onagi J., J. Rebek Jr, Linse S. and Gräslund A.: ‘Specific binding of a β-cyclodextrin dimer to the amyloid β peptide modulates the peptide aggregation process’, Biochemistry, 2012, 51, 4280–4289.
  • Wang H., Zhou Y., Guo Y., Liu W., Dong C., Wu Y. and Songdong L.: ‘β-Cyclodextrin/Fe3O4 hybrid magnetic nano-composite modified glassy carbon electrode for tryptophan sensing’, Sens. Actuators B Chem., 2012, 163, 171–178.
  • Ghosh S., Badruddoza A., Uddin M. and Hidajat K.: ‘Adsorption of chiral aromatic amino acids onto carboxymethyl-β-cyclodextrin bonded Fe3O4/SiO2 core-shell nanoparticles’, J. Colloid Interface Sci., 2011, 354, 483–492.
  • Badruddoza A. Z. M., Hazel G. S. S., Hidajat K. and Uddin M.: ‘Synthesis of carboxymethyl-β-cyclodextrin conjugated magnetic nano-adsorbent for removal of methylene blue’, Colloids Surf. A Physicochem. Eng. Asp., 2010, 367, 85–95.
  • Liao M. H. and Chen D. H.: ‘Preparation and characterization of a novel magnetic nano-adsorbent’, J. Mater. Chem., 2002, 12, 3654–3659.
  • Khurana R., Coleman C., Ionescu-Zanetti C., Carter S. A., Krishna V., Grover R. K., Roy R. and Singh S.: ‘Mechanism of thioflavin T binding to amyloid fibrils’, J. Struct. Biol., 2005, 151, 229–238.
  • Ge S., Shi X., Sun K., Li C., Uher C., J. R. Baker Jr, Holl M. M. B. and Orr B. G.: ‘Facile hydrothermal synthesis of iron oxide nanoparticles with tunable magnetic properties’, J. Phys. Chem. C, 2009, 113, 13593–13599.
  • Badruddoza A., Hidajat K. and Uddin M.: ‘Synthesis and characterization of β-cyclodextrin-conjugated magnetic nanoparticles and their uses as solid-phase artificial chaperones in refolding of carbonic anhydrase bovine’, J. Colloid Interface Sci., 2010, 346, 337–346.
  • Zheng J. C., Feng H. M., Lam M. H. W., Lam P. K. S., Ding Y. W. and Yu H. Q.: ‘Removal of Cu (II) in aqueous media by biosorption using water hyacinth roots as a biosorbent material’, J. Hazard. Mater., 2009, 171, 780–785.
  • Jitianu A., Raileanu M., Crisan M., Predoi D., Jitianu M., Stanciu L. and Zaharescu M.: ‘Fe3O4–SiO2 nanocomposites obtained via alkoxide and colloidal route’, J. Sol-Gel Sci. Technol., 2006, 40, 317–323.
  • Deng Y., Qi D., Deng C., Zhang X. and Zhao D.: ‘Superparamagnetic high-magnetization microspheres with an Fe3O4@ SiO2 core and perpendicularly aligned mesoporous SiO2 shell for removal of microcystins’, J. Am. Chem. Soc., 2008, 130, 28–29.
  • Ji Y., Liu X., Guan M., Zhao C., Huang H., Zhang H. and Wang C.: ‘Preparation of functionalized magnetic nanoparticulate sorbents for rapid extraction of biphenolic pollutants from environmental samples’, J. Sep. Sci., 2009, 32, 2139–2145.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.